Stock Researching

Onyx - Whose Take Is It Anyway?

Stock Researching
Publish date: Wed, 14 Aug 2013, 10:06 AM
Stockresearching is a blog designed to help the independent investor create new ideas and receive valuable informed information.

From Liston Street Pulse:

There have been news/rumors that Amgen (AMGN) and Onyx (ONXX) are discussing the deal all over again and Amgen may raise the offer to $130 per share. While rejecting Amgen's earlier $120 offer, Onyx CEO said in a statement that it is "significantly undervalued." Is it? Onyx's three assets Kyprolis used for treating multiple myeloma […]

The post Onyx - Whose Take Is It Anyway? appeared first on Liston Street Pulse.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment